Nutritional Supplement for Type 2 Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial requires that you maintain your current diabetes medications, including Metformin and up to two other oral anti-diabetic drugs, throughout the study. However, you must stop taking any non-study diabetes-specific oral nutritional supplements and certain other medications or supplements that could affect blood glucose or metabolism at least four weeks before starting the trial.
What data supports the effectiveness of the treatment Oral nutritional supplement for Type 2 Diabetes?
Research shows that diabetes-specific oral nutritional supplements can improve blood sugar control in people with type 2 diabetes by using special ingredients like slowly-digestible carbohydrates and healthy fats. These supplements have been found to help manage blood sugar levels and improve overall health outcomes in both short- and long-term studies.12345
Is the nutritional supplement for Type 2 Diabetes generally safe for humans?
While many people use dietary supplements, there are some risks, including potential side effects and interactions with other medications. Serious adverse events are rare but have been reported, especially with supplements for weight loss and blood sugar control. It's important to talk to your healthcare provider about any supplements you are considering.56789
How is the oral nutritional supplement treatment for type 2 diabetes different from other treatments?
This oral nutritional supplement is unique because it is specifically designed for diabetes, containing slowly-digestible carbohydrates and healthy fats, which help improve blood sugar control and provide long-term benefits for managing diabetes. Unlike standard treatments, it can be used as a meal replacement to help manage weight and blood sugar levels effectively.234510
What is the purpose of this trial?
This study aims to study the effect of an oral nutrition supplement to help manage type-2 diabetes by capturing the metagenomic fingerprint of the small-intestine.
Eligibility Criteria
Adults aged 40-65 with type 2 diabetes, HbA1c levels between 6.5% and 9.5%, BMI of 20-29.9, stable weight, and taking up to three oral diabetic medications including Metformin can join this trial. They must not be pregnant or breastfeeding, have used certain supplements or antibiotics recently, have clotting disorders or active cancer, engage in strenuous exercise, or plan to become pregnant.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Collection of baseline samples for metagenomic and metabolomic analysis
Treatment
Participants ingest the oral nutrition supplement and samples are collected at baseline, midpoint, and endpoint
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Oral nutritional supplement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nimble Science Ltd.
Lead Sponsor
Abbott Nutrition
Industry Sponsor
Robert B. Ford
Abbott Nutrition
Chief Executive Officer since 2020
Bachelor's degree from Boston College, MBA from UC Berkeley, Haas School of Business
Melissa Brotz
Abbott Nutrition
Chief Marketing Officer
Bachelor's degree in Journalism from Northwestern University
University of Calgary
Collaborator